WallachBeth Capital Analyst Recommendations & Stock Picks This page lists the most recent publicly-reported stock recommendations and ratings issued by analysts at WallachBeth Capital. These ratings and price targets were collected from public media reports and are believed to be accurate, but cannot be verified with 100% certainty. MarketBeat and its parent company are in no way affiliated with or endorsed by WallachBeth Capital.MarketBeat Brokerage Ranking: Subscribe to MarketBeat All Access for the recommendation accuracy ratingAverage 12-Month ROI of Buy Recommendations: Subscribe to Unlock Country All Countries United States(NYSE & NASDAQ) United States(All Exchanges) Canada United Kingdom Sector All Sectors Aerospace Auto/Tires/Trucks Basic Materials Business Services Computer and Technology Construction Consumer Discretionary Consumer Goods Consumer Staples Finance Industrials Medical Miscellaneous Multi-Sector Conglomerates Energy Retail/Wholesale Services Transportation Utilities All Market Caps Large Cap ($10B+) Medium Cap ($2B-$10B) Small Cap (<$2B) Market Cap MarketRank™ evaluates a company based on dividend strength, earnings, valuation, analysts forecasts, and more.Available with a MarketBeat All Access SubscriptionMarketRank™Upgrade to All Access to use the All Ranks Filter Media sentiment refers to the percentage of positive news stories versus negative news stories a company has received in the past week.Available with a MarketBeat All Access SubscriptionMedia SentimentUpgrade to All Access to use the All Sentiments Filter Analyst consensus is the average investment recommendation among Wall Street research analysts.Available with a MarketBeat All Access SubscriptionAnalyst ConsensusUpgrade to All Access to use the All Ratings Filter Export to Excel CompanyCurrent PriceReport DateAnalystActionRatingPrice TargetDetailsActionsQUREuniQure$14.99-1.4%12/6/2016-Lower Price TargetBuy$27.00 -> $15.00View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 12/6/2016IRWDIronwood Pharmaceuticals$0.77-2.9%9/27/2016-Boost Price TargetHold$15.00 -> $17.00View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 9/27/2016VTGNVistaGen Therapeutics$2.55+0.4%7/7/2016-Initiated CoverageBuy$510.00View details for WallachBeth Capital rating of VistaGen Therapeutics (NASDAQ:VTGN) on 7/7/2016ESPREsperion Therapeutics$1.17-5.6%7/5/2016-DowngradeBuy -> Hold$35.00View details for WallachBeth Capital rating of Esperion Therapeutics (NASDAQ:ESPR) on 7/5/2016QUREuniQure$14.99-1.4%6/15/2016-Lower Price TargetBuy$60.00 -> $35.00View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 6/15/2016QUREuniQure$14.99-1.4%12/1/2015-Boost Price TargetBuy$33.00 -> $60.00View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 12/1/2015ESPREsperion Therapeutics$1.17-5.6%10/26/2015-Initiated CoverageBuy$34.00View details for WallachBeth Capital rating of Esperion Therapeutics (NASDAQ:ESPR) on 10/26/2015QUREuniQure$14.99-1.4%8/28/2015-Lower Price TargetBuy$35.00 -> $33.00View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 8/28/2015QUREuniQure$14.99-1.4%8/7/2015-Initiated CoverageBuy$35.00View details for WallachBeth Capital rating of uniQure (NASDAQ:QURE) on 8/7/2015GMEDGlobus Medical$56.35-2.1%3/2/2015-Boost Price TargetBuy$26.00 -> $30.00View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 3/2/2015 Get the Latest News and Ratings for Your StocksEnter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter. IRWDIronwood Pharmaceuticals$0.77-2.9%2/13/2015-Boost Price TargetHold$15.00 -> $17.00View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 2/13/2015TENXTenax Therapeutics$5.96+1.4%11/18/2014-Initiated CoverageBuy$384,000.00View details for WallachBeth Capital rating of Tenax Therapeutics (NASDAQ:TENX) on 11/18/2014AKTXAkari Therapeutics$1.138/12/2014-Initiated CoverageBuy$340.00View details for WallachBeth Capital rating of Akari Therapeutics (NASDAQ:AKTX) on 8/12/2014GMEDGlobus Medical$56.35-2.1%8/6/2014-UpgradeHold -> Buy$27.00 -> $24.00View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 8/6/2014INGRIngredion$133.16-1.0%6/18/2014-Initiated CoverageHold$16.00View details for WallachBeth Capital rating of Ingredion (NYSE:INGR) on 6/18/2014IRWDIronwood Pharmaceuticals$0.77-2.9%6/18/2014-Initiated CoverageHold$16.00View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 6/18/2014WBWeibo$10.24+1.1%5/13/2014-DowngradeBuy -> Hold$4.00 -> $2.50View details for WallachBeth Capital rating of Weibo (NASDAQ:WB) on 5/13/2014GMEDGlobus Medical$56.35-2.1%2/27/2014-DowngradeBuy -> Hold$23.00 -> $27.00View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 2/27/2014GMEDGlobus Medical$56.35-2.1%5/17/2013-Initiated CoverageBuy$19.00View details for WallachBeth Capital rating of Globus Medical (NYSE:GMED) on 5/17/2013LHLabcorp$243.73-1.4%4/12/2013-DowngradeBuy -> Hold$97.00View details for WallachBeth Capital rating of Labcorp (NYSE:LH) on 4/12/2013TMOThermo Fisher Scientific$415.29-2.3%4/4/2013-DowngradeBuy -> Hold$68.00 -> $76.00View details for WallachBeth Capital rating of Thermo Fisher Scientific (NYSE:TMO) on 4/4/2013BMYBristol Myers Squibb$47.40-1.4%3/25/2013-DowngradeBuy -> HoldView details for WallachBeth Capital rating of Bristol Myers Squibb (NYSE:BMY) on 3/25/2013UHSUniversal Health Services$168.99-1.1%3/4/2013-DowngradeBuy -> Hold$61.00View details for WallachBeth Capital rating of Universal Health Services (NYSE:UHS) on 3/4/2013JAZZJazz Pharmaceuticals$112.87-1.7%2/27/2013-Boost Price TargetBuy$63.00 -> $70.00View details for WallachBeth Capital rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 2/27/2013HCAHCA Healthcare$360.91-0.5%2/6/2013-Boost Price TargetHold$31.00 -> $36.00View details for WallachBeth Capital rating of HCA Healthcare (NYSE:HCA) on 2/6/2013WATWaters$287.39-3.2%1/28/2013-UpgradeHold -> Buy$87.00 -> $103.00View details for WallachBeth Capital rating of Waters (NYSE:WAT) on 1/28/2013IRWDIronwood Pharmaceuticals$0.77-2.9%1/16/2013-Boost Price TargetHold$10.00 -> $13.00View details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 1/16/2013BMYBristol Myers Squibb$47.40-1.4%1/8/2013-Boost Price TargetBuy$44.50 -> $49.50View details for WallachBeth Capital rating of Bristol Myers Squibb (NYSE:BMY) on 1/8/2013IRWDIronwood Pharmaceuticals$0.77-2.9%12/18/2012-Initiated CoverageHoldView details for WallachBeth Capital rating of Ironwood Pharmaceuticals (NASDAQ:IRWD) on 12/18/2012LHLabcorp$243.73-1.4%11/13/2012-UpgradeHold -> Buy$91.00 -> $97.00View details for WallachBeth Capital rating of Labcorp (NYSE:LH) on 11/13/2012ESEversource Energy$65.41+0.9%11/13/2012-Boost Price TargetHold$3.50 -> $5.00View details for WallachBeth Capital rating of Eversource Energy (NYSE:ES) on 11/13/2012MYGNMyriad Genetics$4.47-7.3%10/1/2012-Initiated CoverageBuy$31.00View details for WallachBeth Capital rating of Myriad Genetics (NASDAQ:MYGN) on 10/1/2012HSICHenry Schein$69.10-0.6%9/6/2012-Initiated CoverageHoldView details for WallachBeth Capital rating of Henry Schein (NASDAQ:HSIC) on 9/6/2012BMYBristol Myers Squibb$47.40-1.4%9/4/2012-Initiated CoverageBuy$41.00View details for WallachBeth Capital rating of Bristol Myers Squibb (NYSE:BMY) on 9/4/2012MTDMettler-Toledo International$1,197.24-0.7%8/28/2012-Initiated CoverageHold$173.00View details for WallachBeth Capital rating of Mettler-Toledo International (NYSE:MTD) on 8/28/2012LHLabcorp$243.73-1.4%8/27/2012-Initiated CoverageHold$91.00View details for WallachBeth Capital rating of Labcorp (NYSE:LH) on 8/27/2012DGXQuest Diagnostics$166.79-0.8%8/27/2012-Initiated CoverageHoldView details for WallachBeth Capital rating of Quest Diagnostics (NYSE:DGX) on 8/27/2012JAZZJazz Pharmaceuticals$112.87-1.7%8/27/2012-Initiated CoverageBuy$63.00View details for WallachBeth Capital rating of Jazz Pharmaceuticals (NASDAQ:JAZZ) on 8/27/2012 MarketBeat Community Rating for WallachBeth CapitalCommunity Ranking: 2.6 out of 5 (2.6 of 5 stars)Outperform Votes: 49,656 (Vote Outperform)Underperform Votes: 46,923 (Vote Underperform)Total Votes: 96,579MarketBeat's community ratings are surveys of what our community members think about WallachBeth Capital and other research firms. Vote "Outperform" if you believe WallachBeth Capital's recommendations will outperform the S&P 500 over the long term. Vote "Underperform" if you believe WallachBeth Capital's recommendations will underperform the S&P 500 over the long term. You may vote once every thirty days. Stock Forecasts and Research Tools Today's Ratings U.S. Ratings U.K. Ratings Canadian Ratings All Upgrades All Downgrades All Initiations All Price Target Changes Top-Rated Stocks Top Rated Stocks Top-Rated Dividend Stocks Top-Rated Small-Cap Stocks Top-Rated Tech Stocks Most-Upgraded Stocks Most-Downgraded Stocks Lowest-Rated Stocks More Ratings Tools Stock Ratings by Issuer Top-Rated Analysts Top-Rated Brokerages Stock Ratings Screener Free Ratings Newsletter Price Forecasts for Popular Stocks Alphabet (Google) Stock ForecastAmazon Stock ForecastApple Stock ForecastMeta (Facebook) Stock ForecastMicrosoft Stock ForecastNetflix Stock ForecastNvidia Stock ForecastTesla Stock Forecast Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
